Polymeric alginate nanoparticles containing the local anesthetic bupivacaine

References

• Albright GA. (1979). Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology, 51, 285–287.
   PubMed Web of Science ®Google Scholar
• Alonso MJ. (2004). Nanomedicines for overcoming biological barriers. Biomed Pharmacother, 58, 168–172.
   PubMed Web of Science ®Google Scholar
• de Araújo DR, Braga AFA, Moraes CM, Fraceto LF, de Paula E. (2006). Mistura com excesso enantiomérico de 50% (S75–R25) de bupivacaina complexada com ciclodextrinas e anestesia por via subaracnoidea em ratos. Rev Bras Anestesiol, 56, 495–506.
   PubMedGoogle Scholar
• de Araujo DR, Cereda CM, Brunetto GB, Pinto LM, Santana MH, de Paula E. (2004). Encapsulation of mepivacaine prolongs the analgesia provided by sciatic nerve blockade in mice. Can J Anaesth, 51, 566–572.
   PubMed Web of Science ®Google Scholar
• de Araujo DR, Cereda CM, Brunetto GB, Vomero VU, Pierucci A, Neto HS, de Oliveira AL, Fraceto LF, Braga Ade F, de Paula E. (2008a). Pharmacological and local toxicity studies of a liposomal formulation for the novel local anaesthetic ropivacaine. J Pharm Pharmacol, 60, 1449–1457.
   PubMed Web of Science ®Google Scholar
• de Araújo DR, Fraceto LF, Braga AFA, de Paula E. (2005). Sistemas de liberação controlada com bupivacaína racêmica (S50-R50) e mistura enantiomérica de bupivacaína (S75–R25): efeitos da complexação com ciclodextrinas no bloqueio do nervo ciático em camundongos. Rev Bras Anestesiol, 55, 316–328.
   PubMedGoogle Scholar
• de Araújo DR, Pinto LMA, Braga AFA, de Paula E. (2003). Formulações de anestésicos locais de liberação controlada: aplicações terapêuticas. Rev Bras Anestesiol, 53, 663–671.
   PubMedGoogle Scholar
• de Araujo DR, Tsuneda SS, Cereda CM, Del G F Carvalho F, Preté PS, Fernandes SA, Yokaichiya F, Franco MK, Mazzaro I, Fraceto LF, de F A Braga A, de Paula E. (2008a). Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex. Eur J Pharm Sci, 33, 60–71.
   PubMed Web of Science ®Google Scholar
• Brasseur N, Brault D, Couvreur P. (1991). Adsorption of hematoporphyrin onto poly-alkylcyanoacrylate nanoparticles: carrier capacity and drug release. Int J Pharm, 70, 129–135.
   Google Scholar
• Calvo P, Vila-Jato JL, Alonso MJ. (1996). Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. J Pharm Sci, 85, 530–536.
   PubMed Web of Science ®Google Scholar
• Cangiani LH, Cangiani LM, Pereira AM de SA. (2007). Bupivacaína com excesso Enantiomérico (S75–R25) a 0,5%, bupivacaína racêmica a 0,5% e lidocaína a 2% no bloqueio do nervo facial pela técnica de O’Brien: estudo comparativo. Rev Bras Anestesiol, 57, 136–146.
   PubMedGoogle Scholar
• Casati A, Santorsola R, Aldegheri G, Ravasi F, Fanelli G, Berti M, Fraschini G, Torri G. (2003). Intraoperative epidural anesthesia and postoperative analgesia with levobupivacaine for major orthopedic surgery: a double-blind, randomized comparison of racemic bupivacaine and ropivacaine. J Clin Anesth, 15, 126–131.
   PubMed Web of Science ®Google Scholar
• Chavanpatil MD, Khdair A, Patil Y, Handa H, Mao G, Panyam J. (2007). Polymer-surfactant nanoparticles for sustained release of water-soluble drugs. J Pharm Sci, 96, 3379–3389.
   PubMed Web of Science ®Google Scholar
• Clarkson CW, Hondeghem LM. (1985). Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology, 62, 396–405.
   PubMed Web of Science ®Google Scholar
• Colombo P, Bettini R, Massimo G, Catellani PL, Santi P, Peppas NA. (1995). Drug diffusion front movement is important in drug release control from swellable matrix tablets. J Pharm Sci, 84, 991–997.
   PubMed Web of Science ®Google Scholar
• Colombo G, Padera R, Langer R, Kohane DS. (2005). Prolonged duration anesthesia with lipid-protein-sugar particles containing bupivacaine and dexamethasone. J Biomed Mater Res, 75A, 458–464.
   Web of Science ®Google Scholar
• Coppi G, Iannuccelli V, Leo E, Bernabei MT, Cameroni R. (2002). Protein immobilization in crosslinked alginate microparticles. J Microencapsul, 19, 37–44.
   PubMed Web of Science ®Google Scholar
• Costa C, Lobo JMS. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13, 123–133.
   PubMed Web of Science ®Google Scholar
• Das RK, Kasoju N, Bora U. (2009). Encapulation of curcumin in alginate–chitosan–pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine: Nanotechnol, Biol Med, 6, e153–e160.
   PubMed Web of Science ®Google Scholar
• Denizot F, Lang R. (1986). Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods, 89, 271–277.
   PubMed Web of Science ®Google Scholar
• Douglas KL, Piccirillo CA, Tabrizian M. (2006). Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles. J Control Release, 115, 354–361.
   PubMed Web of Science ®Google Scholar
• Durán N, Mattoso LHC, Morais PC. (2006). Nanotecnologia. São Paulo, Brazil: Artliber.
   Google Scholar
• Ferrero C, Muñoz-Ruiz A, Jiménez-Castellanos MR. (2000). Fronts movement as a useful tool for hydrophilic matrix release mechanism elucidation. Int J Pharm, 202, 21–28.
   PubMed Web of Science ®Google Scholar
• Gamisans F, Lacoulonche F, Chauvet A, Espina M, García ML, Egea MA. (1999). Flurbiprofen-loaded nanospheres: analysis of the matrix structure by thermal methods. Int J Pharm, 179, 37–48.
   PubMed Web of Science ®Google Scholar
• Gantenbein M, Abat C, Attolini L, Pisano P, Emperaire N, Bruguerolle B. (1997). Ketamine effects on bupivacaine local anaesthetic activity and pharmacokinetics of bupivacaine in mice. Life Sci, 61, 2027–2033.
   PubMed Web of Science ®Google Scholar
• González-Rodríguez ML, Holgado MA, Sánchez-Lafuente C, Rabasco AM, Fini A. (2002). Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm, 232, 225–234.
   PubMed Web of Science ®Google Scholar
• Görner T, Gref R, Michenot D, Sommer F, Tran MN, Dellacherie E. (1999). Lidocaine-loaded biodegradable nanospheres. I. Optimization Of the drug incorporation into the polymer matrix. J Control Release, 57, 259–268.
   PubMed Web of Science ®Google Scholar
• Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. (1999). PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release, 57, 171–185.
   PubMed Web of Science ®Google Scholar
• Grant GJ, Bansinath M. (2001). Liposomal delivery systems for local anesthetics. Reg Anesth Pain Med, 26, 61–63.
   PubMed Web of Science ®Google Scholar
• Grillo R, de Melo NFS, de Araújo DR, de Paula E, Dias Filho NL, Rosa AH, Fraceto LF. (2009). Validation of an HPLC method for quantitative determination of benzocaine in PHBV-microparticles and PLA-nanoparticles. Latin Am J Pharmacy, 28, 393–399.
   Web of Science ®Google Scholar
• Guterres SS, Fessi H, Barratt G, Devissaguet J-Ph, Puisieux F. (1995). Poly (dl-lactide) nanocapsules containing diclofenac: I. Formulation and stability study. Int J Pharm, 113, 57–63.
   Web of Science ®Google Scholar
• Hariharan D, Peppas NA, Bettini R, Colombo P. (1994). Mathematical analysis of drug delivery from swellable systems with partial physical restrictions or impermeable coatings. Int J Pharm, 112, 47–54.
   Web of Science ®Google Scholar
• Haug A, Larsen B. (1962). Quantitative determination of the uronic acid composition of alginates. Acta Chem Scand, 16, 1908–1918.
   Google Scholar
• Joo HH, Lee HY, Guan YS, Kim J-C. (2008). Colloidal stability and in vitro permeation study of poly(e-caprolactone) nanocapsules containing hinokitiol. J Ind Eng Chem, 14, 608–613.
   Web of Science ®Google Scholar
• Khan KA. (1975). The concept of dissolution efficiency. J Pharm Pharmacol, 27, 48–49.
   PubMed Web of Science ®Google Scholar
• Khan KA, Rhodes CT. (1972). A comparative evaluation of some alginates as tablet disintegrants. Pharm Acta Helv, 47, 41–50.
   PubMedGoogle Scholar
• Kilic AC, Capan Y, Vural I, Gursoy RN, Dalkara T, Cuine A, Hincal AA. (2005). Preparation and characterization of PLGA nanospheres for the targeted delivery of NR2B-specific antisense oligonucleotides to the NMDA receptors in the brain. J Microencapsul, 22, 633–641.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm, 15, 25–35.
   Web of Science ®Google Scholar
• Korsmeyer RW, Peppas NA. (1991). Macromolecular and modeling aspects of swelling-controlled systems. In Roseman TJ, Mansdorf SZ, eds. Controlled Release Delivery Systems. New York, USA: Marcel Dekker, Inc.
   Google Scholar
• Kuzma PJ, Kline MD, Calkins MD, Staats PS. (1997). Progress in the development of ultra-long-acting local anesthetics. Reg Anesth, 22, 543–551.
   PubMedGoogle Scholar
• Lee DW, Yun KS, Ban HS, Choe W, Lee SK, Lee KY. (2009). Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery. J Control Release, 139, 146–152.
   PubMed Web of Science ®Google Scholar
• Leszczynska K, Kau ST. (1992). A sciatic blockade method to differentiate drug-induced local anesthesia from neuromuscular blockade in mice. J Pharmacol Meth, 27, 85–93.
   Google Scholar
• Li Z, Chen P, Xu X, Ye X, Wang J. (2009). Preparation of chitosan-sodium alginate microcapsules containing ZnS nanoparticles and its effect on the drug release. Mater Sci Eng C, 29, 2250–2253.
   Web of Science ®Google Scholar
• Magenheim B, Benita STP. (1991). Nanoparticle characterization: a comprehensive physicochemical approach. Pharma Sci, 1, 221–241.
   Google Scholar
• Malamed SF. (2001). Manual de anestesia local. Rio de Janeiro, Brazil: Guanabara Koogan.
   Google Scholar
• Martinsen AA, Skajak-Break G, Smidsrod O. (1997). Comparison of different methods for determination of molecular weight and molecular weight distribution of alginates. Carbohydr Polym, 15, 171–193.
   Google Scholar
• Mi FL, Sung HW, Shyu SS. (2002). Drug release from chitosan–alginate complex beads reinforced by a naturally occurring crosslinking agent. Carbohydr Polym, 48, 61–72.
   Web of Science ®Google Scholar
• Mohanraj VJ, Chen Y. (2006). Nanoparticles—a review. Tropical J Pharm Res, 5, 561–573.
   Google Scholar
• Moraes CM, Abrami P, de Paula E, Braga AF, Fraceto LF. (2007). HPLC and solubility study of the interaction between S (–) bupivacaine and hydroxypropyl-β-cyclodextrin. Int J Pharm, 331, 99–106.
   PubMed Web of Science ®Google Scholar
• Moraes CM, de Paula E, Rosa AH, Fraceto LF. (2008). Validação de metodologia analítica por cromatografia líquida de alta eficiência para quantificação de bupivacaína (S75–R25) em nanoesferas de poli(lactídeo-co-glicolídeo). Quím Nova, 31, 2152–2155.
   Google Scholar
• Moraes CM, Abrami P, de Araujo DR, Braga AFA, Issa MG, Ferraz HG, de Paula E, Fraceto LF. (2007). Characterization of lidocaine:hydroxypropyl-b-cyclodextrin inclusion complex. J Incl Phenom Macrocycl Chem. 57, 313–316.
   Web of Science ®Google Scholar
• Némati F, Dubernet C, Fessi H, Colin De Verdiere A, Poupon MF, Puisieux F, Couvreur P. (1996). Reversion of multidrug resistance using nanoparticles in vitro: influence of the nature of the polymer. Int J Pharm, 138, 237–246.
   Web of Science ®Google Scholar
• Paavola A, Yliruusi J, Kajimoto Y, Kalso E, Wahlström T, Rosenberg P. (1995). Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block. Pharm Res, 12, 1997–2002.
   PubMed Web of Science ®Google Scholar
• Park CJ, Park SA, Yoon TG, Lee SJ, Yum KW, Kim HJ. (2005). Bupivacaine induces apoptosis via ROS in the Schwann cell line. J Dent Res, 84, 852–857.
   PubMed Web of Science ®Google Scholar
• de Paula E, Cereda CM, Tofoli GR, Franz-Montan M, Fraceto LF, de Araújo DR. (2010). Drug delivery systems for local anesthetics. Recent Pat Drug Deliv Formul, 4, 23–34.
   PubMedGoogle Scholar
• Polakovic M, Görner T, Gref R, Dellacherie E. (1999). Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. J Control Release, 60, 169–177.
   PubMed Web of Science ®Google Scholar
• Rose JS, Neal JM, Kopacz DJ. (2005). Extended-duration analgesia: update on microspheres and liposomes. Reg Anesth Pain Med, 30, 275–285.
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ferreira D, Veiga F, Ribeiro A. (2006). Characterization of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr Polym, 66, 1–7.
   Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, Neufeld R, Ferreira D. (2005). Insulin-loaded alginate/chitosan nanoparticles produced by ionotropic pre-gelation. Rev Portugu Farmácia, LII, 139–140.
   Google Scholar
• Schaffazick SR, Guterres SS, Freitas LL, Pohlmann AR. (2003). Caracterização e estabilidade físico-química de sistemas poliméricos nanoparticulados para administração de fármacos. Quim. Nova, 26, 726–737.
   Web of Science ®Google Scholar
• Soppimath KS, Kulkarni AR, Aminabhavi TM. (2001). Chemically modified polyacrylamide-g-guar gum-based crosslinked anionic microgels as pH-sensitive drug delivery systems: preparation and characterization. J Control Release, 75, 331–345.
   PubMed Web of Science ®Google Scholar
• Sriamornsak P, Thirawong N, Korkerd K. (2007). Swelling, erosion and release behavior of alginate-based matrix tablets. Eur J Pharm Biopharm, 66, 435–450.
   PubMed Web of Science ®Google Scholar
• Takka S, Acartürk F. (1999). Calcium alginate microparticles for oral administration: I: Effect of sodium alginate type on drug release and drug entrapment efficiency. J Microencapsul, 16, 275–290.
   PubMed Web of Science ®Google Scholar
• Udelsmann A, Lorena SE, Girioli SU, Silva WA, de Moraes AC. (2007). Hemodynamic effects of the acute intoxication with bupivacaine, levobupivacaine and 50% enantiomeric excess mixture: an experimental study in pigs. Rev Bras Anestesiol, 57, 63–73.
   PubMedGoogle Scholar
• Venkatraman SS, Jie P, Min F, Freddy BY, Leong-Huat G. (2005). Micelle-like nanoparticles of PLA-PEG-PLA triblock copolymer as chemotherapeutic carrier. Int J Pharm, 298, 219–232.
   PubMed Web of Science ®Google Scholar
• Vila A, Sánchez A, Tobío M, Calvo P, Alonso MJ. (2002). Design of biodegradable particles for protein delivery. J Control Release, 78, 15–24.
   PubMed Web of Science ®Google Scholar
• You J, Peng C. (2005). Calcium-alginate nanoparticles formed by reverse microemulsion as gene carriers. Macromol Symp, 219, 147–153.
   Google Scholar
• Zhang H, Lu Y, Zhang G, Gao S, Sun D, Zhong Y. (2008). Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release. Int J Pharm, 351, 244–249.
   PubMed Web of Science ®Google Scholar